Analyze Diet
Equine veterinary journal2012; 45(1); 66-73; doi: 10.1111/j.2042-3306.2012.00575.x

Evaluation of basal plasma α-melanocyte-stimulating hormone and adrenocorticotrophic hormone concentrations for the diagnosis of pituitary pars intermedia dysfunction from a population of aged horses.

Abstract: The sensitivity and specificity of basal plasma α-melanocyte-stimulating hormone (α-MSH) and adrenocorticotrophic hormone (ACTH) for the diagnosis of pituitary pars intermedia dysfunction (PPID) has not been evaluated in a population-based study. Objective: To evaluate basal plasma α-MSH and ACTH concentrations for the diagnosis of PPID in a population of horses aged ≥ 15 years. Methods: Owner-reported data were obtained using a postal questionnaire distributed to an equestrian group. A subgroup of surveyed owners was visited and veterinary examination performed on horses aged ≥ 15 years. Blood samples were analysed for plasma α-MSH and ACTH concentrations. Seasonally adjusted cut-off values for α-MSH and ACTH concentrations for the diagnosis of PPID were obtained using Youden index values against a clinical gold standard diagnosis (hirsutism plus 3 or more clinical signs of PPID). Results: α-melanocyte-stimulating hormone and ACTH were highly correlated with each other and with clinical and historical indicators of PPID. The increase in both α-MSH and ACTH with increasing numbers of clinical signs in affected horses supports a spectrum of disease. Both variables were affected by season, with derived cut-off values being higher in autumn compared with other seasons. Sensitivity and specificity were moderate and good in nonautumn seasons (59 and 93%, respectively) for α-MSH using a cut-off of 52.0 pmol/l. Sensitivity and specificity were good in nonautumn seasons (80 and 83%, respectively) for ACTH using a cut-off of 29.7 pg/ml. For both α-MSH and ACTH, sensitivity and specificity were close to 100% for samples obtained during the autumn period. Conclusions: Basal plasma α-MSH and ACTH had moderate-to-good sensitivity and specificity for the diagnosis of PPID, which improved substantially during the autumn period, suggesting this may be the ideal time to test. Further studies to develop seasonally adjusted reference intervals for different geographical locations are warranted.
Publication Date: 2012-05-06 PubMed ID: 22563728DOI: 10.1111/j.2042-3306.2012.00575.xGoogle Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research aims to evaluate the reliability of basal plasma α-melanocyte-stimulating hormone (α-MSH) and adrenocorticotrophic hormone (ACTH) for diagnosing pituitary pars intermedia dysfunction (PPID) in horses that are 15 years and older. Their findings suggest that these hormone concentrations are highly affected by seasons, making them most accurate during autumn for diagnosing PPID.

Objectives and Methods

  • The goal of the study was to examine the use of basal plasma α-MSH and ACTH to diagnose PPID in an aging horse population. PPID is a common condition in older horses that affects the pituitary gland.
  • Data was collected from horse owners through a postal questionnaire which invited them for the horse’s veterinary examination.
  • Further, the blood samples of horses aged 15 years and older were analysed for the concentrations of α-MSH and ACTH hormones.
  • Seasonally adjusted cut-off values for these hormones that help in diagnosing PPID were obtained using the Youden index, which is a method to determine optimal cut-off points.

Results

  • The findings show that α-MSH and ACTH are highly correlated with each other, as well as with clinical and historical indicators of PPID. This indicates that these hormone levels could be an effective way of diagnosing this condition.
  • Through the study, it’s suggested that there’s a spectrum of PPID severity, demonstrated by the increasing hormone levels with increased clinical signs.
  • Of special note, the hormone concentrations in the cattle were found to fluctuate with seasons, particularly they had higher derived cut-off values in autumn compared to other seasons.
  • The sensitivity and specificity, which reflects the test accuracy, were found to be moderate to good in non-autumn seasons, while it approached 100% for samples obtained during autumn season.

Conclusions

  • The study concludes that basal plasma α-MSH and ACTH have moderate-to-good sensitivity and specificity for diagnosing PPID in aged horses. These results improve significantly during the autumn season, suggesting that autumn may be the ideal time to test for PPID using this method.
  • It further suggests the need for additional studies to develop seasonally adjusted reference intervals for different geographical locations, adding more versatility to this diagnostic method.

Cite This Article

APA
Mc Gowan TW, Pinchbeck GP, Mc Gowan CM. (2012). Evaluation of basal plasma α-melanocyte-stimulating hormone and adrenocorticotrophic hormone concentrations for the diagnosis of pituitary pars intermedia dysfunction from a population of aged horses. Equine Vet J, 45(1), 66-73. https://doi.org/10.1111/j.2042-3306.2012.00575.x

Publication

ISSN: 2042-3306
NlmUniqueID: 0173320
Country: United States
Language: English
Volume: 45
Issue: 1
Pages: 66-73

Researcher Affiliations

Mc Gowan, T W
  • Faculty of Natural Resources, Agriculture and Veterinary Science, University of Queensland, Gatton, Australia. cmcgowan@liverpool.ac.uk
Pinchbeck, G P
    Mc Gowan, C M

      MeSH Terms

      • Adrenocorticotropic Hormone / blood
      • Adrenocorticotropic Hormone / genetics
      • Adrenocorticotropic Hormone / metabolism
      • Aging / physiology
      • Animals
      • Data Collection
      • Horse Diseases / blood
      • Horse Diseases / diagnosis
      • Horse Diseases / metabolism
      • Horses
      • Pituitary ACTH Hypersecretion / diagnosis
      • Pituitary ACTH Hypersecretion / veterinary
      • Pituitary Gland, Intermediate / metabolism
      • Surveys and Questionnaires
      • alpha-MSH / blood
      • alpha-MSH / genetics
      • alpha-MSH / metabolism

      Citations

      This article has been cited 18 times.
      1. Drozdzewska K, Gehlen H. Markers for internal neoplasia in the horse. Vet Med Sci 2023 Jan;9(1):132-143.
        doi: 10.1002/vms3.1042pubmed: 36495211google scholar: lookup
      2. Kirkwood NC, Hughes KJ, Stewart AJ. Prospective Case Series of Clinical Signs and Adrenocorticotrophin (ACTH) Concentrations in Seven Horses Transitioning to Pituitary Pars Intermedia Dysfunction (PPID). Vet Sci 2022 Oct 17;9(10).
        doi: 10.3390/vetsci9100572pubmed: 36288186google scholar: lookup
      3. Kirkwood NC, Hughes KJ, Stewart AJ. Pituitary Pars Intermedia Dysfunction (PPID) in Horses. Vet Sci 2022 Oct 10;9(10).
        doi: 10.3390/vetsci9100556pubmed: 36288169google scholar: lookup
      4. Kam YN, McKenzie K, Coyle M, Bertin FR. Repeatability of a thyrotropin-releasing hormone stimulation test for diagnosis of pituitary pars intermedia dysfunction in mature horses. J Vet Intern Med 2021 Nov;35(6):2885-2890.
        doi: 10.1111/jvim.16281pubmed: 34642962google scholar: lookup
      5. Tsuchiya T, Noda R, Ikeda H, Maeda M, Sato F. Relationship between endogenous plasma adrenocorticotropic hormone concentration and reproductive performance in Thoroughbred broodmares. J Vet Intern Med 2021 Jul;35(4):2002-2008.
        doi: 10.1111/jvim.16145pubmed: 34028083google scholar: lookup
      6. Tatum RC, McGowan CM, Dean RS, Ireland JL. Equine pituitary pars intermedia dysfunction: Identifying research priorities for diagnosis, treatment and prognosis through a priority setting partnership. PLoS One 2021;16(1):e0244784.
        doi: 10.1371/journal.pone.0244784pubmed: 33395695google scholar: lookup
      7. Horn R, Stewart AJ, Jackson KV, Dryburgh EL, Medina-Torres CE, Bertin FR. Clinical implications of using adrenocorticotropic hormone diagnostic cutoffs or reference intervals to diagnose pituitary pars intermedia dysfunction in mature horses. J Vet Intern Med 2021 Jan;35(1):560-570.
        doi: 10.1111/jvim.16017pubmed: 33368633google scholar: lookup
      8. Morrison PK, Newbold CJ, Jones E, Worgan HJ, Grove-White DH, Dugdale AH, Barfoot C, Harris PA, Argo CM. Effect of age and the individual on the gastrointestinal bacteriome of ponies fed a high-starch diet. PLoS One 2020;15(5):e0232689.
        doi: 10.1371/journal.pone.0232689pubmed: 32384105google scholar: lookup
      9. Hodge E, Kowalski A, Torcivia C, Lindborg S, Stefanovski D, Hart K, Frank N, van Eps A. Effect of thyrotropin-releasing hormone stimulation testing on the oral sugar test in horses when performed as a combined protocol. J Vet Intern Med 2019 Sep;33(5):2272-2279.
        doi: 10.1111/jvim.15601pubmed: 31432575google scholar: lookup
      10. de Laat MA, Reiche DB, Sillence MN, McGree JM. Incidence and risk factors for recurrence of endocrinopathic laminitis in horses. J Vet Intern Med 2019 May;33(3):1473-1482.
        doi: 10.1111/jvim.15497pubmed: 30972832google scholar: lookup
      11. de Laat MA, Sillence MN, Reiche DB. Phenotypic, hormonal, and clinical characteristics of equine endocrinopathic laminitis. J Vet Intern Med 2019 May;33(3):1456-1463.
        doi: 10.1111/jvim.15419pubmed: 30697823google scholar: lookup
      12. Morrison PK, Newbold CJ, Jones E, Worgan HJ, Grove-White DH, Dugdale AH, Barfoot C, Harris PA, Argo CM. The Equine Gastrointestinal Microbiome: Impacts of Age and Obesity. Front Microbiol 2018;9:3017.
        doi: 10.3389/fmicb.2018.03017pubmed: 30581426google scholar: lookup
      13. Meier A, Reiche D, de Laat M, Pollitt C, Walsh D, Sillence M. The sodium-glucose co-transporter 2 inhibitor velagliflozin reduces hyperinsulinemia and prevents laminitis in insulin-dysregulated ponies. PLoS One 2018;13(9):e0203655.
        doi: 10.1371/journal.pone.0203655pubmed: 30212530google scholar: lookup
      14. Spelta CW. Equine pituitary pars intermedia dysfunction: current perspectives on diagnosis and management. Vet Med (Auckl) 2015;6:293-300.
        doi: 10.2147/VMRR.S74191pubmed: 30101114google scholar: lookup
      15. Carmalt JL, Waldner CL, Allen AL. Equine pituitary pars intermedia dysfunction: An international survey of veterinarians' approach to diagnosis, management, and estimated prevalence. Can J Vet Res 2017 Oct;81(4):261-269.
        pubmed: 29081583
      16. Banse HE, Holbrook TC, Frank N, McFarlane D. Relationship of skeletal muscle inflammation with obesity and obesity-associated hyperinsulinemia in horses. Can J Vet Res 2016 Jul;80(3):217-24.
        pubmed: 27408335
      17. Rendle DI, Duz M, Beech J, Parkin T, Durham AE. Investigation of single and paired measurements of adrenocorticotropic hormone for the diagnosis of pituitary pars intermedia dysfunction in horses. J Vet Intern Med 2015 Jan;29(1):355-61.
        doi: 10.1111/jvim.12489pubmed: 25312676google scholar: lookup
      18. Vaughn SA, Lemons MB, Hart KA. The Effect of Season and Breed on Hypothalamic-Pituitary-Adrenal Axis Hormones, Metabolic Hormones, and Oxidative Markers in Ponies and Horses. J Vet Intern Med 2025 Mar-Apr;39(2):e70047.
        doi: 10.1111/jvim.70047pubmed: 40048369google scholar: lookup